ask="7.75"
ask_size="100"
average_daily_volume="961587"
bid="5.75"
bid_size="800"
book_value="0.05"
change="-0.46"
change_from_200_day_moving_average="0.86"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-1.46"
change_From_52_week_low="4.36"
change_in_percent="-7.01%"
close="6.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="46578000"
high="6.63"
high_52_weeks="7.56"
last_trade_date="2/21/2017"
last_trade_price="6.10"
last_trade_size="32830"
last_trade_time="4:00pm"
low="6.05"
low_52_weeks="1.74"
market_capitalization="449.92M"
moving_average_200_day="5.24"
moving_average_50_day="6.17"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.10"
open="6.60"
pe_ratio="N/A"
peg_ratio="-0.36"
percent_change_from_200_day_moving_average="+16.48%"
percent_change_from_50_day_moving_average="-1.10%"
percent_change_from_52_week_high="-19.31%"
percent_change_from_52_week_low="+251.58%"
previous_close="6.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="121.48"
price_per_sales="22.02"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1274512"
weeks_range_52="1.74 - 7.56"
